“…Further, dNHLs rarely undergo localized ischemic necrosis and offer other advantages (Del Vecchio et al, 1991). To reduce the chance of cell emigration and immigration, which may falsify MI and AI, especially in generalized dNHL, we restricted the selected cases to stage I ϩ II (''localized'') disease according to the pathologic Ann Arbor classification (Carbone et al, 1971).Estimates for the value of X were based on the assumptions that most dNHLs are continuously growing neoplasias and that spontaneous lymphoma regression (Krikorian et al, 1980) is a rare event.The fraction of Ki-67 ϩ cells (Gerdes et al, 1993) also was assessed. In addition, we registered the percentages of cells immunoreactive for the bcl-2 protein, which counteracts apoptosis (Reed, 1994).…”